111In-BPDA

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Name111In-BPDA

Drug Alias Name111In radiolabeled BBN-PEG-DTPA-AuNP (Institute of Nuclear Energy Research/National Taipei University of Technology/National Yang-Ming University/Shin Kong Wu Ho-Su Memorial Hospital)

ClassificationRadiation-emitting productsBiologics > Protein drugs > Recombinant polypeptide

Mechanisms of ActionUpdating

TargetsUpdating

Therapy Area/IndicationsNeoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryTaiwan

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesInstitute Of Nuclear Energy Research, Taiwan

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesInstitute Of Nuclear Energy Research, Taiwan

Active IndicationsN/A

Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A